MedPath

Comparison of the effects of Citalopram Versus Fluoxetine on motor function after stroke.

Phase 2
Conditions
Cerebral infarction.
Sequelae of cerebral infarction
Registration Number
IRCT20141116019971N3
Lead Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Over 18 years of age
Suffering from hemiparesis or hemiplegia as a result of a first-time acute (in the past 24 hours) ischemic stroke
An initial Fugl-Meyer Motor Scale score of under 55

Exclusion Criteria

A National Institutes of Health Stroke Scale score of less than five
Prior disabilities including aphasia, cognitive disorders and motor disorders due to stroke or any other neurodegenerative disease
Pregnancy or breastfeeding
Currently taking antidepressants
Contraindications of therapy, including renal insufficiency (glomerular filtration rate <30 ml/min), abnormal liver function tests, hyponatremia and a long QT interval on an electrocardiogram and
Any significant adverse effects (agitation, hypertension or other signs of serotonin syndrome) after initiation of treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Motor function. Timepoint: At recruitment and after 90 days. Method of measurement: Fugl-Meyer Motor Scale score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath